loading

Finanzdaten der Janux Therapeutics Inc-Aktie (JANX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
49.13%
1.252
2.461 2.517 1.057 2.048
Operating Expenses
15.14%
21.41
18.60 18.33 21.80 22.33
Benefits Costs and Expenses
12.61%
16.01
14.22 14.09 18.57 19.51
Costs And Expenses
12.61%
16.01
14.22 14.09 18.57 19.51
Operating Income/Loss
24.94%
-20.16
-16.14 -15.81 -20.75 -20.28
Nonoperating Income/Loss
23.34%
5.401
4.379 4.245 3.24 2.822
Income/Loss From Continuing Operations Before Tax
25.53%
-14.76
-11.76 -11.57 -17.51 -17.46
Income/Loss From Continuing Operations After Tax
25.53%
-14.76
-11.76 -11.57 -17.51 -17.46
Net Income/Loss
25.53%
-14.76
-11.76 -11.57 -17.51 -17.46
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,357%
49.05
0.8989 45.71 41.84 41.76
Diluted Average Shares
5,357%
49.05
0.8989 45.71 41.84 41.76
Basic Earnings Per Share
25.00%
-0.30
-0.24 -0.25 -0.42 -0.42
Diluted Earnings Per Share
25.00%
-0.30
-0.24 -0.25 -0.42 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):